Leading CDM from Today’s Challenges to a Visionary Future
Following a highly-successful SCDM 2018 EMEA Forum in London (UK) on May 2018, we are pleased to announce that the SCDM Leadership Forum will take place during this year’s Annual Conference.
On Sunday 23rd, September, our global Leadership series continues in Seattle-Bellevue. Over the course of the forum, we will go on a highly interactive journey in three parts. The focus areas of the event are as follows:
- Challenges Clinical Data Management leaders face today
- Rapidly evolving technologies to address these challenges
- Re-imagining the discipline of Clinical Data Management for the future
Starting with a roundtable discussion, we will consider our industry’s top challenges in data management and how we can tackle these to progress from present to future. The forum will also include panel discussions on the current and upcoming regulations and their impact on our work. In order to understand the interface between regulation and technology, we will recieve key updates from the SCDM Innovation Committee.
If you would like to attend the Leadership Forum, please fill out the application form accessible below. Please note that the Leadership Forum gathers senior leaders in the Clinical Data Management sector, and we will review your application in line with these criteria.
We are looking forward to welcoming you to Seattle-Bellevue.
Please note : Should you have already received an invitation to the Leadership Forum over email, you do not need to apply to attend the Forum. Please email firstname.lastname@example.org to process your registration or for any further questions.
Meet the Leadership Forum Speakers
Christopher P. Lamplugh, MBA, Head of Global Data Management and Standards (GDMS), Merck Research
Over his 15 years working at Merck, Christopher has been involved on multiple programs across several therapeutic areas as a leader in Data Management. Chris also led the creation, expansion and operationalization of Merck’s Data Management Centers (DMCs). Prior to Merck, Chris worked for General Electric for 10 years in Sales Management, Sales Force Effectiveness and Quality. He is a certified Six Sigma Black Belt and is active in many initiatives and forums within the pharmaceutical industry. Christopher holds a BA from Ursinus College and an MBA from Penn State, with coursework in Health Policy from Jefferson University.
Demetris Zambas, VP and Global Head of Data Monitoring and Management, Pfizer, Inc.
With his extensive experience and leadership in the industry for over 27 years and with a history of organizational re-engineering and systems implementations, Demetris leads Pfizer’s Data Management and Risk Based Monitoring line functions in a new transformation; developing and transitioning into an internal operational model and organization across multiple geographic sites in support of Pfizer’s WRD, GPD, PEH and Vaccines portfolio. Demetris holds a Bachelor Degree in Biological Sciences/Microbiology from Rutgers University. He currently serves as an Advisor to the Society of Clinical Data Management (SCDM) Board of Trustees and was the Chair of SCDM in 2016.
Francois Torche, CEO, Cluepoints
Gary Thompson, Medidata
Gregg Dearhammer, Director, Sr. Vice President, IQVIA
A biopharmaceutical industry veteran with more than 20 years of experience, Gregg recently joined IQVIA in November of 2017. Prior to joining IQVIA, he served as Chief Operating Officer at inVentiv Health Clinical, where he was responsible for all aspects of clinical operations. A strong operational leader, Gregg grew one of the largest DSSR FSP operations in the CRO industry and has leveraged his strong client relationships and customer service focus to drive business success throughout his career.
Greg Jones, Director of product strategy, Oracle Health Sciences
Jonathan Andrus, BA, MS, CCDM, CQA, COO and Data Officer, Clinical Ink, Inc.
As Chief Operating Officer, Jonathan Andrus leads Clinical Ink’s global data management and quality & compliance teams to help drug sponsors better leverage eSource data. With 20+ years of experience, Mr. Andrus brings extensive expertise developing eClinical services that integrate data and technology to help life science companies optimize study execution. An active thought leader, blogger and presenter, Jonathan served as chair of the Society for Clinical Data Management (SCDM) in 2008 and 2014 and currently serves as the society’s Treasurer. He is a Certified Quality Auditor (CQA) and Certified Clinical Data Manager (CCDM®).
Linda King, SCDM Vice Chair, Asc. Data Management Director Astellas and Incoming Chair
MaryAnne Rizk, PhD, President, Rizk Management Consulting
With a Bachelors of Engineering, a Masters in Business Management and a PhD in Technology Management , Dr. MaryAnne Rizk has 20+ years of experience transforming the way the biopharmaceutical industry manages digital health. Prior to joining Oracle, MaryAnne founded and led Medidata’s CRO Partner program and at Merck she led both clinical and commercial outsourced technology initiatives. Effective in building enterprise clinical outsourcing collaborations, MaryAnne enables organizations to leverage innovative SaaS cloud-based platform technologies to accelerate drug/device development among lifescience stakeholders: Pharma, Emerging Bio, MedTech, CROs. Dr. Rizk is an active leader and speaker on healthcare innovation by chairing various board memberships.
Paul Slater, Microsoft
Patrick Nadolny, MS, Vice President, Product Management, Clinical Solutions Allergan
Steve Chartier, PAREXEL Informatics
Meet the Leadership Forum Facilitators
Head of Data Management, Global Biometrics – Biogen
Sanjay is the Global Head of Data Management at Biogen. In his current role, Sanjay is responsible for all aspects of DM Portfolio and Project Management, Database Development and Reporting, External Data Acquisition, Clinical & Safety Coding, and eCOA implementations across all of Biogen’s portfolio. Prior to joining Biogen, Sanjay held various leadership roles at Novartis, Merck (MSD), and Schering-Plough. With 20+ years of experience in managing clinical data and systems and leading large-scale technology and business process re-engineering efforts, Sanjay is passionate about the discipline of Clinical Data Management and its contribution to the noble mission of bringing life-savings treatments to the patients.
Asset Lead, Inflammation and Immunology Therapeutics – Pfizer
Carol, an Asset Lead in the Inflammation and Immunology therapeutic area at Pfizer, has 25+ years of Pharma experience where she started in research as a protein biochemist and moved into the Clinical Data Management arena in 2000. She has experience in both Early and Late Phase clinical development, both in project management as well as line management. Her therapeutic areas of experience are in Cardiovascular, Metabolism, Inflammation, Immunology, Infectious Diseases, Rare Diseases and Ophthalmology and she also has expertise in all aspects of outsourcing, including study and project oversight as well as global team leadership and governance. Carol holds both Bachelor’s and Master’s degrees in Biology (specializing in Biotechnology) from William Paterson University.